Anti-IDH1 (clone A2E8) Recombinant Antibody Coupled Liposome (VS-1024-FY106) (CAT#: VS-1024-FY106)
Liposomes that are engineered to specifically bind to anti-IDH1 antibodies have emerged as a promising therapeutic approach for the treatment of gliomas, particularly in patients with the prevalent IDH1 R132H mutation. This mutation has been shown to have a significant impact on the immune response, potentially impairing the activity of anti-tumor T cells, which makes it a critical target for enhancing immunotherapeutic strategies. By focusing on IDH1 as a therapeutic target, researchers aim to not only increase the efficacy of existing treatments but also to rejuvenate the immune system's ability to combat tumor cells more effectively.

(Immunofluorescent staining of human cell line A-431 shows localization to nuclear bodies & cytosol.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/62556/1538_D1_6_selected.jpg

(Hepatocytes Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous nuclear)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/35248/142542_A_7_4.jpg

(Leydig cells Staining: High Intensity: Strong Quantity:>75% Sertoli cells Staining: Medium Intensity: Moderate Quantity:>75%)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/35248/142542_A_6_6.jpg

(Glandular cells Staining: High Intensity: Strong Quantity:>75% Location: Cytoplasmic/ membranous nuclear)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/35248/142542_A_1_5.jpg

(Cell lines ordered by descending RNA expression order)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000138413-IDH1
Specifications
- Potential Clinical Applications
- Glioma
Product Composition
- Clone
- A2E8
- Antibody Type
- IgG
- Antibody Host
- Mouse
- Antibody Reactivity
- Human
- Antibody Description
- This is a recombinant mouse monoclonal antibody designed to specifically target and bind to human isocitrate dehydrogenase 1 (IDH1). IDH1 is a crucial enzyme involved in cellular metabolism, and its mutations are often associated with various types of cancer.
Product Property
- Storage
- See in the COA
- Storage Shelf Time
- See in the COA
Target Information
- Target
- IDH1
- Introduction
- Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. It contains the PTS-1 peroxisomal targeting signal sequence. The presence of this enzyme in peroxisomes suggests roles in the regeneration of NADPH for intraperoxisomal reductions, such as the conversion of 2, 4-dienoyl-CoAs to 3-enoyl-CoAs, as well as in peroxisomal reactions that consume 2-oxoglutarate, namely the alpha-hydroxylation of phytanic acid. The cytoplasmic enzyme serves a significant role in cytoplasmic NADPH production. Alternatively spliced transcript variants encoding the same protein have been found for this gene.
- Alternative Names
- Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic
- Full Name
- Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic
- Gene ID
- 3417
- UniProt ID
- O75874
- Sequence Similarities
- Belongs to the isocitrate and isopropylmalate dehydrogenases family.
- Cellular Localization
- Cytoplasm, cytosol, Peroxisome
- Post Translation Modifications
- Acetylation at Lys-374 dramatically reduces catalytic activity. ( O75874-IDHC_HUMAN )
Ubiquitination at Lys126, Lys224, Lys233, and Lys321 ( NX_O75874 [NX_O75874-1] )
Modification sites at PhosphoSitePlus ( O75874 )
Glycosylation from GlyGen (O75874) 3 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (2 sites)
- Protein Refseq
- NP_001269315.1; NP_001269316.1; NP_005887.2
- Function
- Catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (D-threo-isocitrate) to 2-ketoglutarate (2-oxoglutarate), which is required by other enzymes such as the phytanoyl-CoA dioxygenase (PubMed:10521434, 19935646).
Plays a critical role in the generation of NADPH, an important cofactor in many biosynthesis pathways.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone A2E8"
See other products for "IDH1"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1615z | Mouse Anti-IDH1 Recombinant Antibody (clone 27C2) | WB, FC, IF, IHC | Mouse IgG1, κ |
MRO-0876-CN | Mouse Anti-IDH1 Recombinant Antibody (clone A11-B4) | WB, IHC | Mouse IgG1 |
VS3-FY721 | Recombinant Rabbit Anti-IDH1 Antibody (clone R05-2G5) | WB, IHC-P, IP | Rabbit IgG |
VS7-0425-WR112 | Mouse Anti-IDH1 Recombinant Antibody (clone 4A4A8) | WB, FC | Mouse IgG1 |
VS7-0425-WR113 | Mouse Anti-IDH1 Recombinant Antibody (clone 7G8A1) | WB, ICC, FC | Mouse IgG1 |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1024-FY106. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application:
Application: WB, IF, FuncS
Application: ELISA, FC
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, PD, Activ, PK, Stim
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.